[Investigation, treatment and surveillance of late-onset hypogonadism in males: the official guidelines of the International Society for the Study of the Aging Male (ISSAM) with comments].
There is growing interest in the hormonal changes of the ageing male, particularly in view of the expected growth of the population of males over the age of 50. Current research topics essentially concern androgen decline in the aging male (ADAM), or partial androgen deficiency of the aging male (PADAM), commonly called "andropause" in France. Although progress has been made in our knowledge concerning androgen deficiency of the aging male, it is still incomplete, sometimes confused, and some aspects of androgen replacement therapy remain controversial. The International Society for the Study of the Aging Male (ISSAM) therefore considered it appropriate to propose a series of practical and official guidelines concerning the investigation, treatment and surveillance of late-onset hypogonadism in males. The French translation of these recent international guidelines is presented and discussed in this article.
Cuzin
Béatrice
B
Service d'Urologie, Hôpital Edouard Herriot, Lyon, France.
Giuliano
François
F
Jamin
Christian
C
Legros
Jean-Jacques
JJ
Lejeune
Hervé
H
Rigot
Jean-Marc
JM
Roger
Marc
M
D000367:Age Factors; D006801:Humans; D007006:Hypogonadism / Q000175:diagnosis* / Q000188:drug therapy*; D008297:Male; D011159:Population Surveillance; D011795:Surveys and Questionnaires